by Antonio Regalado from MIT Technology Review on (#74K75)
After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week-saying it had raised money to create nonsentient monkey organ sacks" as an alternative to animal testing. In an interview with Wired, R3 listed three investors: billionaire Tim Draper, the Singapore-based fund Immortal...